Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

478
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
478
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

285
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
285
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

4.9K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
4.9K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

2.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Teratogenicity01:07

Teratogenicity

3.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
An Overview of the Endocrine System01:10

An Overview of the Endocrine System

12.5K
The endocrine system, a complex network of glands, orchestrates physiological balance within the body through the production and secretion of hormones. These hormones are chemical messengers in intercellular communication, acting as conduits between the secretory cells and distant target sites. They traverse the circulatory system by being released into the extracellular fluid, and their impact is specific to cells possessing receptors for a particular hormone.
The endocrine system collaborates...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal blood pressure changes in relation to urinary toxic/essential metals and metal mixtures.

Environmental research·2026
Same author

Arsenic attenuates responsiveness to inflammatory stimuli in the SIM-A9 microglial cell line.

Neurotoxicology·2026
Same author

Per- and polyfluoroalkyl substances (PFAS) and fish consumption in the Great Lakes Fish Consumer Study (GLFCS).

Chemosphere·2026
Same author

Antimony: a cryptic metabolism disruptor ubiquitous in food contact materials.

Journal of the Endocrine Society·2026
Same author

Toxic metals impact gut microbiota and metabolic risk in five African-origin populations.

Gut microbes reports·2026
Same author

Vitamin D deficiency alters prostate epithelial differentiation and increases prostate cancer aggressiveness in ex vivo and in vivo models.

bioRxiv : the preprint server for biology·2026
Same journal

The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Pathophysiology-Based Classification of Male Infertility: Evidence from an 800-patient Prospective Cohort.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Parathyroid Carcinoma: From Molecular Pathogenesis to Multidisciplinary Management.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Genetic and Clinical Factors Associated With Metformin Plasma Concentrations Following an Acute Metformin Challenge.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes.

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Related Experiment Video

Updated: Dec 16, 2025

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.4K

Unwitting Accomplices: Endocrine Disruptors Confounding Clinical Care.

Matthew Genco1, Lisa Anderson-Shaw2, Robert M Sargis1,3

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, IL, US.

The Journal of Clinical Endocrinology and Metabolism
|July 3, 2020
PubMed
Summary
This summary is machine-generated.

Healthcare settings expose patients to endocrine-disrupting chemicals (EDCs) through medical products, potentially harming health and treatment efficacy. Increased awareness, product labeling, and patient education are crucial for ethical medical care.

More Related Videos

Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

10.2K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.2K

Related Experiment Videos

Last Updated: Dec 16, 2025

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

6.4K
Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

10.2K
Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model
04:14

Author Spotlight: In Vivo Assessment of Thyroid Hormone Disruption Using the THAI Mouse Model

Published on: October 6, 2023

1.2K

Area of Science:

  • Endocrinology
  • Environmental Health
  • Medical Ethics

Background:

  • Endocrine-disrupting chemicals (EDCs) are synthetic compounds impacting hormone function.
  • EDCs are linked to reproductive, metabolic, and developmental diseases.
  • Healthcare is an underappreciated source of EDC exposure.

Purpose of the Study:

  • To highlight the ethical implications of healthcare-associated EDC exposure.
  • To underscore the need for increased provider knowledge and patient disclosure regarding EDCs in medical interventions.

Main Methods:

  • Review of existing evidence on EDC impacts.
  • Analysis of ethical principles in medical practice.
  • Identification of gaps in current medical product screening and labeling.

Main Results:

  • Medical products (medications, devices) can contain EDCs, acting as exposure vectors.
  • Failure to disclose EDC properties in healthcare violates patient rights and informed consent.
  • Physician unawareness of EDCs skews risk-benefit assessments.

Conclusions:

  • Healthcare providers must be educated on endocrine disruption.
  • Medical products containing known EDCs require clear labeling.
  • Screening of medical products for EDCs and improved patient communication are essential for ethically sound care.